We are live on
!
Find out more
DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Est. Return
2.74%
This Fund
S&P 500
This Quarter
Est. Return
-11.83%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$842M
AUM Growth
-$157M
(-16%)
Cap. Flow
-$26.2M
Cap. Flow
% of AUM
-3.11%
Top 10 Holdings %
Top 10 Hldgs %
22.59%
Holding
314
New
7
Increased
68
Reduced
159
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$7.34M |
| 2 |
RTX Corp
RTX
|
+$4.13M |
| 3 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$4.01M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$3.43M |
| 5 |
Vanguard Emerging Markets Government Bond ETF
VWOB
|
+$3.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Preferred ETF
PGX
|
+$11.4M |
| 2 |
Medpace
MEDP
|
+$4.81M |
| 3 |
Apple
AAPL
|
+$4.18M |
| 4 |
Toll Brothers
TOL
|
+$3.76M |
| 5 |
Invesco Emerging Markets Sovereign Debt ETF
PCY
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.39% |
| 2 | Healthcare | 13.79% |
| 3 | Financials | 9.83% |
| 4 | Consumer Staples | 6.84% |
| 5 | Industrials | 6.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Elevance Health
ELV
$80.9B
| $5.64M | 0.67% |
11,681
-477
| -4% | -$236K |
|
52
Verizon
VZ
$182B
| $5.49M | 0.65% |
108,209
-2,026
| -2% | -$102K |
|
53
Unilever
UL
$134B
| $5.11M | 0.61% |
99,147
+315
| +0.3% | +$16K |
|
54
Salesforce
CRM
$140B
| $5.1M | 0.61% |
30,875
-1,419
| -4% | -$251K |
|
55
Coca-Cola
KO
$351B
| $5.06M | 0.6% |
80,476
-674
| -0.8% | -$42.7K |
|
56
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $4.88M | 0.58% |
12,937
+2,146
| +20% | +$879K |
|
57
Bristol-Myers Squibb
BMY
$124B
| $4.79M | 0.57% |
62,172
-2,725
| -4% | -$208K |
|
58
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $4.64M | 0.55% |
92,638
-3,467
| -4% | -$175K |
|
59
VanEck IG Floating Rate ETF
FLTR
$2.88B
| $4.56M | 0.54% |
184,620
-2,885
| -2% | -$72K |
|
60
Schwab US Dividend Equity ETF
SCHD
$100B
| $4.34M | 0.52% |
181,605
-5,925
| -3% | -$151K |
|
61
Kimberly-Clark
KMB
$36B
| $4.33M | 0.51% |
32,040
-66
| -0.2% | -$8.7K |
|
62
Corteva
CTVA
$58.4B
| $4.33M | 0.51% |
79,879
-3,555
| -4% | -$206K |
|
63
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
| $4.31M | 0.51% |
85,299
-12,548
| -13% | -$639K |
|
64
Cigna
CI
$74.5B
| $4.29M | 0.51% |
16,277
-1,673
| -9% | -$431K |
|
65
Estee Lauder
EL
$29.7B
| $4.17M | 0.49% |
16,362
-394
| -2% | -$100K |
|
66
Norfolk Southern
NSC
$76.4B
| $4.15M | 0.49% |
18,247
-1,243
| -6% | -$305K |
|
67
Cisco
CSCO
$441B
| $3.94M | 0.47% |
92,373
-2,188
| -2% | -$105K |
|
68
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.36B
| $3.8M | 0.45% |
78,333
-3,259
| -4% | -$159K |
|
69
General Dynamics
GD
$99.7B
| $3.72M | 0.44% |
16,820
-262
| -2% | -$60.3K |
|
70
FedEx
FDX
$74.7B
| $3.67M | 0.44% |
16,202
-33
| -0.2% | -$7.04K |
|
71
MSCI
MSCI
$45.8B
| $3.59M | 0.43% |
8,720
-125
| -1% | -$54.4K |
|
72
Chevron
CVX
$373B
| $3.52M | 0.42% |
24,340
-284
| -1% | -$46.9K |
|
73
JPMorgan Chase
JPM
$907B
| $3.42M | 0.41% |
30,400
-1,777
| -6% | -$220K |
|
|
74
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.21B
| $3.4M | 0.4% |
55,545
+51,713
| +1,350% | +$3.35M |
|
75
Duke Energy
DUK
$97.5B
| $3.4M | 0.4% |
31,733
-1,286
| -4% | -$141K |
|
Similar funds
BDWM
MCM
TFM
MWM
CP
BWM
FPS
IC
Dixon Hubard Feinour & Brown's Q2 2022 Portfolio in Review
As of Q2 2022, Dixon Hubard Feinour & Brown held 314 positions worth $842M, down 16% from $999M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Dixon Hubard Feinour & Brown withdrew a net $26.2M in Q2 2022, closing 35 positions and reducing 159 holdings. Its most notable exit was Medpace, an estimated $4.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Dixon Hubard Feinour & Brown opened a new position in Iron Mountain worth $361K.
- Dixon Hubard Feinour & Brown's largest Q2 2022 buy was Iron Mountain: 7,418 shares worth $361K.
- Dixon Hubard Feinour & Brown added most to UnitedHealth in Q2 2022, an estimated $7.34M increase.
- Dixon Hubard Feinour & Brown's biggest Q2 2022 reduction was Invesco Preferred ETF, cutting an estimated $11.4M.
- Dixon Hubard Feinour & Brown fully exited Medpace in Q2 2022, selling an estimated $4.81M.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 23% of its $842M portfolio in Q2 2022.
- Dixon Hubard Feinour & Brown opened 7 new positions and closed 35 in Q2 2022.
- Dixon Hubard Feinour & Brown's portfolio value fell 16% quarter-over-quarter to $842M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.